Castle Biosciences, Inc.CSTLNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank63
3Y CAGR+28.7%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
+28.7%/yr
vs -59.3%/yr prior
Acceleration
+88.0pp
Accelerating
Percentile
P63
Within normal range
vs 3Y Ago
2.1x
Strong expansion
Streak
5 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.06+28.7%
20240.05+46.6%
20230.03+12.9%
20220.03+68.9%
20210.02-
20200.00-100.0%
20190.21-80.8%
20181.09-42.3%
20171.89-